Shiseido Company (4911) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
13 Jun, 2025Introduction of external director
Yoshihiko Hatanaka, with extensive leadership experience at Astellas Pharma and other major firms, has served as Shiseido's external director since March 2023 and became chair of the Compensation Committee in March 2024.
Key features of corporate governance
Shiseido defines governance as a system supporting sustainable growth and long-term value.
The company transitioned to a "Company with Three Statutory Committees" to separate oversight and execution, enhancing agility and strategic alignment.
The board focuses on adapting to volatile environments through in-depth discussion and effective monitoring.
New governance structure (as of March 31, 2024)
Board consists of 11 directors, with 63.6% external and 45.4% female representation.
Nominating and Compensation Committees are solely comprised of external directors; Audit Committee is chaired by an external director.
Non-executive directors make up 81.8% of the board, supporting strong oversight.
Latest events from Shiseido Company
- Profit and cash flow beat targets in 2025; 2026 aims for higher margins and dividends.4911
Q4 202510 Feb 2026 - Sales up 2.9%, profit down 31.3% as China and Travel Retail lag, Japan and EMEA grow.4911
Q2 20242 Feb 2026 - Profit slumped as China and Travel Retail underperformed despite Japan's growth.4911
Q3 202416 Jan 2026 - 2024 profit fell on restructuring, but 2025 targets recovery and growth in Japan and EMEA.4911
Q4 202427 Dec 2025 - Growth, innovation, and sustainability drive global leadership and profitability.4911
Investor Day 202525 Dec 2025 - Core profit up 21.3% year-over-year on cost cuts, offsetting a 6% sales decline.4911
Q2 202523 Nov 2025 - Core profit rose 9.7% in Q3 2025, but a ¥46.8bn impairment drove a net loss and outlook cut.4911
Q3 202518 Nov 2025 - Core profit met targets despite sales and profit declines, with outlook and cost controls maintained.4911
Q1 20256 Jun 2025